Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
|
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). |
Juvenile Psoriatic Arthritis | Phase1 | United States | NCT06751238 |
|
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis |
Diffuse Cutaneous Systemic Sclerosis | Phase2 |
Argentina Austria Belgium Brazil China Colombia France Germany Greece Hungary India Italy Japan Malaysia Mexico Poland Portugal South Korea Spain Taiwan Thailand Turkey (Türkiye) United Kingdom United States Vietnam View all
|
NCT06470048 |
|
Post Marketing Study on Pluvicto in Korea |
Metastatic Castration-resistant Prostate Cancer | South Korea | NCT06514521 | |
|
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers | Phase1 |
Belgium China France Germany Israel Italy Japan Norway Singapore South Korea Spain Sweden Taiwan United Kingdom United States View all
|
NCT05838768 |
|
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA |
ANCA Associated Vasculitis (AAV) | Phase2 |
Brazil Israel Japan Saudi Arabia Singapore Switzerland United Kingdom United States View all
|
NCT06868290 |
|
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis |
Aortic Stenosis | Phase2 |
Austria Belgium Canada Czechia Denmark France Germany Israel Italy Netherlands Portugal Spain Switzerland United Kingdom United States View all
|
NCT05646381 |
|
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer |
Breast Cancer |
Jordan Oman Saudi Arabia United Arab Emirates View all
|
NCT06075758 | |
|
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. |
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease, Glomerulonephritis, IGA, Glomerulopathy, Immunoglobulin Disease | Phase3 |
Argentina South Korea United States |
NCT06858319 |
|
Dabrafenib and/or Trametinib Rollover Study |
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma | Phase4 |
Spain United States |
NCT03340506 |
|
CAR-T Long Term Follow Up (LTFU) Study |
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | Phase3 |
Australia Austria Belgium Canada China Denmark Finland France Germany Greece Hong Kong Israel Italy Japan Norway Saudi Arabia Singapore South Korea Spain Taiwan United Kingdom United States View all
|
NCT02445222 |